- Women of reproductive potential must have a negative serum beta human chorionic gonadotropin (beta HCG) pregnancy test obtained within 2 days before the start of anetumab ravtansine. Women not of reproductive potential are female subjects who are postmenopausal or permanently sterilized (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy).